We are live on ! Find out more
LSA

L & S Advisors Portfolio holdings

AUM $795M
1-Year Est. Return 52.77%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+52.77%
3 Year Est. Return
+187.16%
5 Year Est. Return
+324.2%
10 Year Est. Return
+1,741.32%
AUM
$251M
AUM Growth
+$63.7M
Cap. Flow
+$47.8M
Cap. Flow %
19.04%
Top 10 Hldgs %
44.41%
Holding
104
New
24
Increased
40
Reduced
18
Closed
22

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$6.02M
2
MMM icon
3M
MMM
+$4.44M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$4.1M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$4.04M
5
HAL icon
Halliburton
HAL
+$3.91M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.73M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.49M
3
QCOM icon
Qualcomm
QCOM
+$2.27M
4
KLAC icon
KLA
KLAC
+$2.25M
5
AMGN icon
Amgen
AMGN
+$2.13M

Sector Composition

Rank Sector Weight
1 Communication Services 23.8%
2 Energy 17.91%
3 Industrials 17.42%
4 Healthcare 13.85%
5 Materials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.82T
$4.01M 1.6%
556,420
+233,190
+72% +$1.57M
DAL icon
27
Delta Air Lines
DAL
$55.9B
$3.97M 1.58%
102,581
+42,712
+71% +$1.61M
TMO icon
28
Thermo Fisher Scientific
TMO
$211B
$3.81M 1.52%
32,275
+15,180
+89% +$1.79M
RTN
29
DELISTED
Raytheon Company
RTN
$3.71M 1.48%
40,250
+19,361
+93% +$1.88M
WHR icon
30
Whirlpool
WHR
$2.42B
$3.59M 1.43%
25,810
+11,619
+82% +$1.71M
CBI
31
DELISTED
Chicago Bridge & Iron Nv
CBI
$3.04M 1.21%
44,641
+20,425
+84% +$1.62M
AZN icon
32
AstraZeneca
AZN
$263B
$2.71M 1.08%
36,522
+27,970
+327% +$2.02M
PEP icon
33
PepsiCo
PEP
$186B
$2.37M 0.94%
26,546
+23,053
+660% +$1.99M
DD icon
34
DuPont de Nemours
DD
$18.6B
$2.29M 0.91%
17,610
-433
-2% -$55.2K
PXD
35
DELISTED
Pioneer Natural Resource Co.
PXD
$2.28M 0.91%
+9,940
New +$2.05M
KMB icon
36
Kimberly-Clark
KMB
$36.4B
$2.23M 0.89%
+20,885
New +$2.22M
PG icon
37
Procter & Gamble
PG
$343B
$2.17M 0.86%
27,620
+24,104
+686% +$1.94M
WLL
38
DELISTED
Whiting Petroleum Corporation
WLL
$2.11M 0.84%
+88
New +$1.95M
CMI icon
39
Cummins
CMI
$91.7B
$2.06M 0.82%
13,330
-421
-3% -$63.7K
FCX icon
40
Freeport-McMoran
FCX
$90B
$2.05M 0.82%
+56,122
New +$1.92M
OAK
41
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$2.03M 0.81%
+40,677
New +$2.11M
ROC
42
DELISTED
ROCKWOOD HLDGS INC
ROC
$2M 0.8%
26,390
-1,243
-4% -$91.4K
EMN icon
43
Eastman Chemical
EMN
$7.8B
$2M 0.8%
22,923
-1,174
-5% -$102K
CLX icon
44
Clorox
CLX
$11.6B
$1.93M 0.77%
+21,144
New +$1.89M
KMI icon
45
Kinder Morgan
KMI
$73.1B
$1.92M 0.77%
+53,032
New +$1.79M
WMB icon
46
Williams Companies
WMB
$90.5B
$1.61M 0.64%
27,747
+21,187
+323% +$982K
OKE icon
47
Oneok
OKE
$58.7B
$1.46M 0.58%
21,404
+13,363
+166% +$845K
IYR icon
48
iShares US Real Estate ETF
IYR
$4.59B
$1.43M 0.57%
+19,939
New +$1.4M
COP icon
49
ConocoPhillips
COP
$147B
$963K 0.38%
11,233
+8,197
+270% +$639K
TRGP icon
50
Targa Resources
TRGP
$60.4B
$957K 0.38%
6,855
+352
+5% +$40.5K
1
2
3 4 5

Similar funds

Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
ACM
Atika Capital Management New York $796M AUM 167.57% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ATS
Ashton Thomas Securities Rochester, New York $797M AUM 18.33% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return

L & S Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, L & S Advisors held 104 positions worth $251M, up 34% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

L & S Advisors deployed $47.8M of net new capital in Q2 2014, opening 24 new positions and adding to 40 existing holdings. Its largest new stake was AbbVie: 114,721 shares worth $6.47M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 29% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Pfizer, an estimated $3.73M trimmed.

  • L & S Advisors's largest Q2 2014 buy was AbbVie: 114,721 shares worth $6.47M.
  • L & S Advisors added most to KRAFT FOODS GROUP INC COM STK (VA) in Q2 2014, an estimated $4.1M increase.
  • L & S Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $3.73M.
  • L & S Advisors fully exited Bristol-Myers Squibb in Q2 2014, selling an estimated $2.49M.
  • L & S Advisors's ten largest holdings make up 44% of its $251M portfolio in Q2 2014.
  • L & S Advisors opened 24 new positions and closed 22 in Q2 2014.
  • L & S Advisors's portfolio value rose 34% quarter-over-quarter to $251M.

Based on L & S Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.